Error loading player: No playable sources found
73562
Keynote Session III: Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
Date
September 7, 2023
This product is not available for individual purchase, but it is available as part of the following products:
Session Speaker:
Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
Jason Rouse, Pfizer, Inc.
Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
Jason Rouse, Pfizer, Inc.
Session Chair
Related Products
The Regulator Panel: Can We Talk?
Featured Panelists:
Session VII: Product and Process Characterization
Assay Replacement Strategies using MAM
Mass Spec 20th Anniversary Vendor Showcase ~ Presented by MOBILion Systems, Inc.
HOS attendees should grab their lunch and proceed to the meal room to eat…
Keynote Session I: Quantitative Proteomics for Understanding Histone Mutations in Human Disease
Quantitative Proteomics for Understanding Histone Mutations in Human Disease (45 minutes)
